Characterization of the nicotinic ligand 2-[18F]Fluoro-3-[2(S)-2 azetidinylmethoxy]pyridine in vivo

Life Sciences

Volumn 64, Issue 5, 1999, Pages

  Valette, Héric ^a,b   Bottlaender, Michel ^a   Dollé, Frédéric ^a   Guenther, Ilonka ^a   Coulon, Christine ^a   Hinnen, Françoise ^a   Fuseau, Chantal ^a   Ottaviani, Michele ^a   Crouzel, Christian ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b DIF   (France)

Author keywords

2 18F fluoro 3 2(S) 2 azetidinylmethoxy pyridine; 18F fluorine; nAChR; Positron emission tomography

Indexed keywords

2 FLUORO 3 [2 (2 AZETIDINYLMETHOXY)]PYRIDINE; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; CYTISINE; DEXETIMIDE; EPIBATIDINE; FLUORINE 18; MECAMYLAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PENETRATION; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RECEPTOR DENSITY; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMUS;

ALKALOIDS; ANIMALS; AZETIDINES; AZOCINES; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; BRAIN; CEREBELLUM; FLUORINE RADIOISOTOPES; FRONTAL LOBE; KINETICS; LIGANDS; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; QUINOLIZINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; THALAMUS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0033601478     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 1. J.O. Rinne, R. Myllykylä, P. Lönnberg and P. Marjamäki. Brain. Res. 547 167-170 (1991).
2. 2. C. Gotti, D. Fornasari and F. Clementi. Prog. Neurobiol. 53 199-237 (1977).
3. 3. M. Mazière, D. Comar, C. Marazano and G. Berger. Eur. J. Nucl. Med. 1 255-258 (1977).
4. 4. C. Halldin , K. Någren, C.G. Swahn , B. Långström and H. Nybäck. Nucl. Med. Biol. 19 871-880 (1992).
5. 5. H. Nybäck, C. Halldin, A. Ahlin, M. Curvall and L. Eriksson. Psychopharmacol. 115 31-36 (1994).
6. 6. E.P. Broussolle, D.F. Wong, R.J. Fanellia and E.D. London. Life Sci. 44 1123-1132 (1989).
7. 7. H. Valette, M. Bottlaender, F. Dollé, L. Dolci, A. Syrota and C. Crouzel. Nucl. Med. Com. 18 164-168 (1997).
8. 8. B. Badio and J.W. Daly. Mol. Pharmacol. 45 563-569 (1994).
9. 9. A.G. Horti, U. Scheffel, M. Stathis, P.A. Finley, H.T. Ravert, E.D. London and R.F. Dannals. J. Nucl. Med. 38 1250-1265 (1997).
10. 10. Y.S. Ding, S.J. Gatley, J.S. Fowler, N.D. Volkow, D. Aggarwal, J. Logan, S.L. Dewey, F. Liang, F.I. Carroll and M. Kuhar. Synapse 24 403-407 (1996).
11. 11. V.L. Villemagne, A.G. Horti, U. Scheffel, H.T. Ravert, P. Finley, D.J. Clough, E.D. London, H.N. Wagner Jr and R.F. Dannals. J. Nucl. Med. 38 1737-1741 (1997).
12. 12. M. Bottlaender, C. Loc'h, M. Kassiou, M. Ottaviani, C. Coulon, B. Tavitian, E. London, J. Musachio, R.F. Dannals and B. Mazière. Soc. Neurosci. Annu. Meeting 23 382 (1997) (Abstr).
13. 13. M. Fisher, D. Huangfu, T.Y. Shen and P.G. Guyenet. J. Pharmacol. Exp. Ther. 270 702-707 (1994).
14. 14. R.A. Houghtling, M.I. Dàvila-Garcia, S.D. Hurt and K.J. Kellarv. Med. Chem. Res. 4 538-546 (1994).
15. 15. R.J. Lukas. J. Pharmacol. Exp. Ther. 265 294-302 (1993).
16. 16. P.E. Molina, Y.S. Ding, I. Carrol, F. Liang, N.D. Volkow, N. Pappas, M. Kuhar, N. Abumrad, S.J. Gatley and J.S. Fowler. Nucl. Med. Biol. 24 743-747 (1997).
17. 17. M.A. Abreo, N.H. Lin, D.S. Garvey, D.E. Gunn, A.M. Hettinger, J.T. Wasicak, P.A. Pavlik, Y.C. Martin, D.L. Donelly-Roberts, D.J. Anderson, J.P. Sullivan, M. Williams, S.P. Arneric and M.W. Holladay. J. Med. Chem. 39 817-825 (1996).
18. 18. J.P. Sullivan, D.L. Donelly-Roberts, C.A. Briggs, D.J. Anderson, M. Gopalakrishnan, M. Piattonikaplan, J.E. Campbell, D.G. McKenna, E. Molinari, A.M. Hettinger, D.S. Garvey, J.T. Wasicak, M.W. Holladay, M. Williams and S.P. Arneric. Neuropharmacol. 35 725-734 (1996).
19. 19. D.J. Anderson, J.E. Campbell, J.L. Raszkiewicz, A.M. Hettinger, D.S. Garvey, S.P. Arneric and J.P. Sullivan. Soc. Neurosci. Annu. Meeting. 21 606 (1995) (Abstr).
20. 20. A.G. Horti, A.O. Koren, U. Scheffer, A.S. Kimes, H.T. Ravert, W.B. Mathews, J.L. Musachio, P.A. Finley, Y. Zhan, R.F. Dannals and E.D. London. Soc. Neurosci. Annu. Meeting. 23 382 (1997) (Abstr).
21. 21. F. Dollé, H. Valette, M. Bottlaender, F. Hinnen, F. Vaufrey, I. Guenther and C. Crouzel. J. Label. Comp. Radiopharm. 41 451-463 (1998).
22. 22. H. Valette, M. Bottlaender, F. Dollé, I. Guenther, C. Fuseau, C. Coulon, M. Ottaviani and C. Crouzel. Submitted to J. Nucl. Med.
23. 23. J.L. Musachio, U. Scheffel, P.A. Finley, Y. Zhan, T. Mochizuki, H.N. Wagner and R.F. Dannals. Life Sci. 62 351-357 (1998).
24. 24. H.K. Happe, J.L. Peters, D.A. Bergman and L.C. Murrin. Neurosci. 62 929-944 (1994).
25. 25. D.C. Perry and K.J. Kellar. J. Pharmacol. Exp. Ther. 275 1030-1034 (1995).